Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 10 studies | 29% ± 14% | |
oligodendrocyte precursor cell | 8 studies | 38% ± 14% | |
astrocyte | 6 studies | 34% ± 14% | |
Mueller cell | 5 studies | 43% ± 15% | |
chondrocyte | 4 studies | 55% ± 22% |
Insufficient scRNA-seq data for expression of COL9A2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 5369.07 | 2600 / 2642 | 96% | 48.04 | 677 / 705 |
prostate | 93% | 2077.00 | 227 / 245 | 96% | 235.26 | 483 / 502 |
thymus | 99% | 1844.75 | 646 / 653 | 57% | 15.00 | 344 / 605 |
bladder | 86% | 1824.67 | 18 / 21 | 59% | 20.90 | 298 / 504 |
uterus | 60% | 822.49 | 102 / 170 | 72% | 47.85 | 330 / 459 |
breast | 55% | 949.51 | 251 / 459 | 66% | 25.24 | 737 / 1118 |
lung | 60% | 545.01 | 347 / 578 | 57% | 21.49 | 663 / 1155 |
kidney | 98% | 2233.63 | 87 / 89 | 19% | 4.13 | 172 / 901 |
stomach | 65% | 1079.75 | 234 / 359 | 42% | 8.49 | 121 / 286 |
intestine | 56% | 771.85 | 537 / 966 | 51% | 12.29 | 271 / 527 |
ureter | 0% | 0 | 0 / 0 | 100% | 89.81 | 1 / 1 |
ovary | 12% | 91.09 | 21 / 180 | 86% | 47.65 | 370 / 430 |
spleen | 94% | 1445.53 | 227 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 43.49 | 27 / 29 |
pancreas | 7% | 53.13 | 22 / 328 | 76% | 19.00 | 136 / 178 |
peripheral blood | 81% | 2579.67 | 754 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 37.77 | 31 / 45 |
esophagus | 23% | 216.77 | 338 / 1445 | 41% | 10.68 | 75 / 183 |
blood vessel | 63% | 1098.43 | 843 / 1335 | 0% | 0 | 0 / 0 |
skin | 38% | 345.91 | 680 / 1809 | 24% | 13.25 | 113 / 472 |
adrenal gland | 40% | 347.63 | 102 / 258 | 16% | 9.69 | 36 / 230 |
eye | 0% | 0 | 0 / 0 | 15% | 4.26 | 12 / 80 |
liver | 0% | 0 | 0 / 226 | 15% | 5.51 | 59 / 406 |
adipose | 14% | 104.88 | 172 / 1204 | 0% | 0 | 0 / 0 |
heart | 5% | 35.79 | 45 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001501 | Biological process | skeletal system development |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005594 | Cellular component | collagen type IX trimer |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
GO_0005515 | Molecular function | protein binding |
Gene name | COL9A2 |
Protein name | Collagen type IX alpha 2 chain Collagen alpha-2(IX) chain |
Synonyms | |
Description | FUNCTION: Structural component of hyaline cartilage and vitreous of the eye. |
Accessions | ENST00000372736.3 B1AKJ3 ENST00000642679.1 ENST00000417105.6 Q14055 A0A2R8YFT7 H0Y409 ENST00000372748.8 |